Besides, we specifically discussed the predictive value of CKS1B for clinical outcomes in subgroups of ACC, and results were shown in Figure 2(c): high expression of CKS1B was an independent risk factor for OS (HR = 2.909, p = 0.032) and progression-free interval (PFI) (HR = 4.497, p = 0.001). Here, CKS1B is linked to adrenal cortex carcinoma.